Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Chemical Synthesis . These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN115043770B enables metal-free indole synthesis. Offers cost reduction and supply chain reliability for high-purity pharmaceutical intermediates manufacturing.
Novel copper-catalyzed ring-opening allylation of cyclopropanols offers high-yield, green route for pharmaceutical intermediates and complex molecule synthesis.
Patent CN113735756A details a novel Rh-catalyzed C-H activation method for chiral 3,3-disubstituted isoindolinones, offering high enantioselectivity and streamlined manufacturing for pharmaceutical intermediates.
Electrochemical preparation of selenium-containing thiazolines via patent CN111235596A. Mild conditions, high purity, ideal for reliable pharmaceutical intermediate supply chains.
Patent CN110963943B details a mild, high-yield one-pot method for aryl amidines using nitrones and isocyanates, offering significant cost reduction and scalability for pharmaceutical intermediates.
Novel visible-light catalytic ruthenium complex enables efficient alkyne-aldehyde addition. Reduces energy costs and simplifies purification for pharmaceutical intermediate manufacturing.
Patent CN110511193B reveals a mild elemental sulfur method for alpha-ketothioamides. Discover cost-effective pharma intermediate manufacturing with high purity.
Patent CN115261896B reveals electrochemical synthesis for high-purity intermediates. Offers cost reduction and supply chain reliability for anticancer drug manufacturing.
Patent CN112126942B details a green electrochemical method for synthesizing hydrazine intermediates, offering cost reduction and scalable manufacturing for pharma applications.
Novel Pd-catalyzed carbonylation method using sulfonyl chlorides avoids smelly thiols, offering cost-effective routes for high-purity pharmaceutical intermediates.
Patent CN111217847B introduces novel thiosilane ligands for iridium-catalyzed C-H borylation, offering superior yield, easier purification, and industrial scalability for pharmaceutical intermediates.
Patent CN111690947B reveals a metal-free electrochemical synthesis for trifluoromethylated arylamides, offering significant cost reduction in API manufacturing and greener processing.
Novel axial chiral phosphine catalyst synthesis via chiral phosphoric acid. High ee, mild conditions. Ideal for asymmetric hydrosilylation and coupling. Reliable supplier for pharma intermediates.
Patent CN110467613B reveals a mild nickel-catalyzed route for isoindolinones, offering significant cost reduction in API manufacturing and enhanced supply chain reliability.
Patent CN102010443B reveals a high-yield copper complex for Henry reactions. Discover cost-effective synthesis routes and reliable supply chain solutions for chiral catalysts.
Patent CN113957461B reveals metal-free electrochemical route for 1,1'-binaphthyl. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Novel Lewis acid-catalyzed rearrangement offers mild conditions and high purity for pharmaceutical intermediate manufacturing and supply chain stability.
Novel carbonylation method using sulfonyl chlorides avoids thiols. High purity API intermediates with scalable, cost-effective production capabilities.
Patent CN112675920B reveals a novel Ruthenium catalyst for efficient chiral alcohol synthesis. Discover cost reduction in pharmaceutical intermediate manufacturing and scalable production methods.
Patent CN112126941B reveals a green electrochemical route for 10-hydroxyphenanthrene derivatives, offering cost-effective and scalable pharmaceutical intermediate manufacturing solutions.